The Boca Virus RNA Detection Qualitative Test is a specialized diagnostic procedure aimed at identifying the presence of Boca virus RNA in a patient's sample. This test employs sophisticated molecular techniques to qualitatively assess whether the genetic material of the Boca virus is present, indicating an active or recent infection. The Boca virus, part of the Parvoviridae family, can cause a range of symptoms from mild to severe, particularly in individuals with weakened immune systems. Early and accurate detection through this test is crucial for timely intervention and management of the infection.
Conducted at DNA Labs UAE, a leading facility in the region for genetic and molecular diagnostics, the test ensures high precision and reliability. The cost of the Boca Virus RNA Detection Qualitative Test is set at 1160 AED. This investment covers the utilization of advanced laboratory technology and expertise to provide patients and healthcare providers with critical information for effective medical decision-making. DNA Labs UAE is known for its commitment to quality, making it a trusted choice for this important health screening.
The Bordetella Pertussis RNA Detection Qualitative Test is a diagnostic tool used to identify the presence of Bordetella pertussis, the bacterium responsible for whooping cough, a highly contagious respiratory disease. This test specifically targets and amplifies the RNA of the bacterium, providing a qualitative assessment of its presence in a patient's sample, usually obtained from a nasopharyngeal swab.
Performed at DNA Labs UAE, a leading laboratory known for its advanced diagnostic techniques, the test utilizes sophisticated molecular methods to ensure high sensitivity and specificity. The cost of the test is set at 1160 AED, reflecting the intricate technology and expertise required to accurately detect the RNA of Bordetella pertussis.
This test is crucial for early diagnosis and timely treatment of whooping cough, especially in populations at high risk such as infants and those with compromised immune systems. Given its precision and the critical information it provides, the Bordetella Pertussis RNA Detection Qualitative Test is an essential tool in the management and control of whooping cough outbreaks.
The "CCHF Crimean Congo Hemorrhagic Fever RNA Detection Qualitative Test" is a diagnostic procedure designed to identify the presence of the RNA of the Crimean-Congo Hemorrhagic Fever (CCHF) virus. This test is qualitative, meaning it aims to detect whether the virus's genetic material is present in the sample, rather than quantifying the amount of virus. The CCHF virus is a tick-borne virus that can cause severe viral hemorrhagic fever outbreaks in humans, with a high mortality rate. Early detection through such tests is crucial for the effective management and treatment of the disease.
The test is conducted at DNA Labs UAE, a facility known for its advanced diagnostic services and state-of-the-art technology. The cost of the test is set at 1160 AED, making it accessible for individuals who are at risk or have been exposed to environments where the CCHF virus is prevalent. This test is significant for its role in public health surveillance, outbreak control, and providing a critical diagnostic tool for healthcare providers in managing suspected cases of Crimean-Congo Hemorrhagic Fever.
The Campylobacter jejuni RNA detection qualitative test is a specialized diagnostic tool used for identifying the presence of Campylobacter jejuni, a bacterium that is one of the most common causes of gastroenteritis worldwide. This test specifically targets the RNA sequences of the bacteria, providing a qualitative assessment of its presence in a sample. Unlike quantitative tests that measure the amount of bacteria, this qualitative test simply indicates whether the bacteria are present or not, without specifying the quantity.
Performed at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and high-quality standards, this test is essential for accurately diagnosing infections caused by Campylobacter jejuni. The process involves collecting a sample from the patient, usually a stool sample, which is then analyzed using sophisticated RNA detection techniques. These techniques are highly sensitive and specific, making them reliable for detecting even low levels of bacterial RNA.
The cost of the Campylobacter jejuni RNA detection qualitative test at DNA Labs UAE is set at 1160 AED. While the price may seem high, it reflects the sophisticated nature of the test and the expertise required to perform it. For patients suffering from symptoms of gastroenteritis, such as diarrhea, fever, and abdominal cramps, this test provides a definitive diagnosis, enabling appropriate treatment and management of the condition.
In summary, the Campylobacter jejuni RNA detection qualitative test is a critical diagnostic tool for identifying infections caused by this bacterium. Offered at DNA Labs UAE for 1160 AED, it employs advanced RNA detection techniques to provide reliable and accurate results, aiding in the effective treatment of affected individuals.
The "MLL AML ALL Test" is a specialized diagnostic procedure designed to detect specific genetic abnormalities associated with various forms of leukemia, including Mixed Lineage Leukemia (MLL), Acute Myeloid Leukemia (AML), and Acute Lymphoblastic Leukemia (ALL). This test plays a crucial role in the accurate diagnosis and classification of these hematological malignancies, enabling healthcare providers to tailor treatment plans to the individual needs of patients.
Conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, the test involves the examination of the patient's genetic material to identify mutations or rearrangements in genes that are commonly associated with these types of leukemia. The process leverages advanced molecular techniques to ensure high sensitivity and specificity in the detection of genetic markers.
The cost of the MLL AML ALL Test at DNA Labs UAE is 1050 AED. This price reflects the sophisticated technology and expertise required to perform this complex analysis. By choosing DNA Labs UAE for this test, patients can expect accurate results, which are crucial for the effective management and treatment of leukemia.
The "MYEOVIgH MM Test" is a specialized diagnostic procedure designed to provide comprehensive insights into specific health concerns, particularly targeting the evaluation of genetic markers associated with multiple myeloma, a type of blood cancer. Conducted at DNA Labs UAE, a leading facility renowned for its advanced genetic testing services, this test plays a crucial role in the early detection and management of multiple myeloma by analyzing the patient's genetic material for any anomalies or predispositions.
Priced at 1050 AED, the MYEOVIgH MM Test is accessible for individuals seeking an in-depth analysis of their genetic risk factors for multiple myeloma. The cost reflects the sophisticated technology and expertise required to accurately identify and interpret the genetic variations that could influence the development of this condition. By opting for this test at DNA Labs UAE, patients can benefit from the lab's state-of-the-art infrastructure and the professional guidance of genetic counselors, ensuring a comprehensive and reliable assessment of their genetic health concerning multiple myeloma.
The PDGFRβ CMML Test is a specialized diagnostic assay designed to detect genetic abnormalities associated with Chronic Myelomonocytic Leukemia (CMML), a type of cancer that affects the blood and bone marrow. This test specifically looks for mutations or rearrangements in the platelet-derived growth factor receptor beta (PDGFRβ) gene, which can play a significant role in the development and progression of CMML. Identifying these genetic markers is crucial for determining the most effective treatment strategy for patients.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing capabilities. The cost of the PDGFRβ CMML Test at DNA Labs UAE is 1050 AED. This investment in diagnostic testing is vital for patients suspected of having CMML, as it provides essential information that can guide personalized treatment plans, potentially leading to better outcomes.
The PDGFRα HES Test, available at DNA Labs UAE for a cost of 1050 AED, is a diagnostic tool designed to identify mutations in the platelet-derived growth factor receptor alpha (PDGFRα) gene. These mutations are often associated with hypereosinophilic syndrome (HES), a group of blood disorders characterized by the overproduction of eosinophils, a type of white blood cell. By detecting specific genetic abnormalities in the PDGFRα gene, this test helps in the diagnosis and management of HES, enabling healthcare providers to tailor treatment strategies effectively. Conducted in the state-of-the-art facilities of DNA Labs UAE, the PDGFRα HES Test is a crucial step towards personalized medicine for patients suffering from this complex condition.
PMLRARA AML - M3 APML Test is a specialized diagnostic procedure aimed at detecting the presence of the PML/RARA fusion gene, which is indicative of Acute Promyelocytic Leukemia (APML), a subtype of Acute Myeloid Leukemia (AML). This test is crucial for the accurate diagnosis and management of APML, as the presence of the PML/RARA gene fusion plays a key role in the disease's pathogenesis and influences treatment strategies. Conducted at DNA Labs UAE, a reputable facility known for its advanced diagnostic technologies and expertise, the test ensures reliable results. The cost for undergoing the PMLRARA AML - M3 APML Test at DNA Labs UAE is set at 1050 AED, reflecting the comprehensive approach and precise analysis involved in identifying this critical genetic marker.
The "PMLRARA Qualitative BCR 1 and 3 Test" is a specialized diagnostic examination aimed at detecting the presence of the PML/RARA fusion gene, which is a hallmark of acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia (AML). This genetic anomaly arises from the translocation between chromosomes 15 and 17, leading to the creation of the PML/RARA fusion gene. The test specifically looks for breakpoints in BCR 1 and BCR 3, which are critical regions affecting the gene's function and the disease's clinical outcome.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves collecting a sample of the patient's blood or bone marrow. The laboratory utilizes sophisticated molecular techniques to qualitatively assess the presence of the PML/RARA fusion gene, providing crucial information for the diagnosis, prognosis, and treatment planning of individuals suspected of having APL.
The cost of the "PMLRARA Qualitative BCR 1 and 3 Test" at DNA Labs UAE is set at 1050 AED. This price reflects the intricate nature of the testing process and the significant impact its results have on the management of patients with acute promyelocytic leukemia. Early detection and confirmation of the PML/RARA fusion gene enable healthcare providers to initiate targeted therapies, significantly improving patient outcomes.
